Company Filing History:
Years Active: 2021
Title: The Innovative Mind of Appala Sagi in Transdermal Drug Delivery
Introduction
Appala Sagi, an accomplished inventor based in Mountain View, CA, has made significant contributions to the field of transdermal drug delivery. With two patents to his name, Sagi's work focuses on innovative methods and compositions for administering therapeutic agents through the skin, showcasing his commitment to improving healthcare solutions.
Latest Patents
Sagi's latest patents center around transdermal adhesive compositions and systems for delivering memantine, a drug commonly used in the treatment of central nervous system disorders such as Alzheimer's disease and dementia. One notable patent describes a transdermal adhesive composition comprising a volatile liquid therapeutic agent that has a low melting point. This patent outlines methods, compositions, and devices that facilitate the transdermal administration of memantine, providing an innovative approach to drug delivery. Another patent describes the detailed structure of transdermal delivery systems, which include a drug reservoir layer made up of an acrylate polymer or copolymer, a permeation enhancer, and memantine base generated in situ. These patents reflect Sagi's focus on creating effective solutions that enhance patient care through advanced drug delivery technologies.
Career Highlights
Appala Sagi’s career is distinguished by his role at Corium Corporation, where he works on developing pioneering transdermal systems. His expertise in this niche has allowed him to delve deeply into pharmaceutical applications, making impactful contributions that align with industry demands for more effective treatment modalities.
Collaborations
Throughout his career, Sagi has collaborated with notable professionals in the pharmaceutical field, including Eun Soo Lee and Parminder Singh. These collaborations underscore the importance of teamwork in driving innovation and achieving breakthroughs in medical technology, particularly in the realm of transdermal drug delivery systems.
Conclusion
Appala Sagi’s innovative work in transdermal drug delivery has the potential to transform how therapeutic agents are administered, improving the efficacy and convenience of treatment for patients with CNS disorders. With his patents paving the way for future advancements, Sagi continues to exemplify the integral role inventors play in advancing healthcare technologies.